S H Friend|F R Gurd - JoVE Visualize

Showing results (71-80 of 95) with videos related to

Pageof 10

Sort By:

Molecular Pharmacology|March 14, 1998

Mining the National Cancer Institute Anticancer Drug Discovery Database: cluster analysis of ellipticine analogs with p53-inverse and central nervous system-selective patterns of activityL M Shi, T G Myers, Y Fan, et al.

Journal of Chemical Information and Computer Sciences|April 16, 1998

Mining the NCI anticancer drug discovery databases: genetic function approximation for the QSAR study of anticancer ellipticine analoguesL M Shi, Y Fan, T G Myers, et al.

American Journal of Human Genetics|March 1, 1995

Germ-line p53 mutations in 15 families with Li-Fraumeni syndromeT Frebourg, N Barbier, Y X Yan, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 15, 1992

Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 proteinT Frebourg, J Kassel, K T Lam, et al.

The EMBO Journal|February 28, 1998

Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpointsW A Cliby, C J Roberts, K A Cimprich, et al.

Cancer Research|February 15, 1996

An abnormality in the p53 pathway following gamma-irradiation in many wild-type p53 human melanoma linesI Bae, M L Smith, M S Sheikh, et al.

Journal of Virology|March 1, 1990

Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma proteinN Dyson, R Bernards, S H Friend, et al.

Proceedings of the National Academy of Sciences of the United States of America|October 1, 1991

Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutationsA L Børresen, E Hovig, B Smith-Sørensen, et al.

Developmental Biology|September 1, 1992

Structure and expression of the Xenopus retinoblastoma geneO H Destrée, K T Lam, L J Peterson-Maduro, et al.

Cancer Research|February 10, 2000

Differential toxicities of anticancer agents among DNA repair and checkpoint mutants of Saccharomyces cerevisiaeJ A Simon, P Szankasi, D K Nguyen, et al.

Pageof 10

Showing results (71-80 of 95) with videos related to

Sort By:

Pageof 10

Molecular Pharmacology|March 14, 1998

Mining the National Cancer Institute Anticancer Drug Discovery Database: cluster analysis of ellipticine analogs with p53-inverse and central nervous system-selective patterns of activityL M Shi, T G Myers, Y Fan, et al.

Journal of Chemical Information and Computer Sciences|April 16, 1998

Mining the NCI anticancer drug discovery databases: genetic function approximation for the QSAR study of anticancer ellipticine analoguesL M Shi, Y Fan, T G Myers, et al.

American Journal of Human Genetics|March 1, 1995

Germ-line p53 mutations in 15 families with Li-Fraumeni syndromeT Frebourg, N Barbier, Y X Yan, et al.

Proceedings of the National Academy of Sciences of the United States of America|July 15, 1992

Germ-line mutations of the p53 tumor suppressor gene in patients with high risk for cancer inactivate the p53 proteinT Frebourg, J Kassel, K T Lam, et al.

The EMBO Journal|February 28, 1998

Overexpression of a kinase-inactive ATR protein causes sensitivity to DNA-damaging agents and defects in cell cycle checkpointsW A Cliby, C J Roberts, K A Cimprich, et al.

Cancer Research|February 15, 1996

An abnormality in the p53 pathway following gamma-irradiation in many wild-type p53 human melanoma linesI Bae, M L Smith, M S Sheikh, et al.

Journal of Virology|March 1, 1990

Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma proteinN Dyson, R Bernards, S H Friend, et al.

Proceedings of the National Academy of Sciences of the United States of America|October 1, 1991

Constant denaturant gel electrophoresis as a rapid screening technique for p53 mutationsA L Børresen, E Hovig, B Smith-Sørensen, et al.

Developmental Biology|September 1, 1992

Structure and expression of the Xenopus retinoblastoma geneO H Destrée, K T Lam, L J Peterson-Maduro, et al.

Cancer Research|February 10, 2000

Differential toxicities of anticancer agents among DNA repair and checkpoint mutants of Saccharomyces cerevisiaeJ A Simon, P Szankasi, D K Nguyen, et al.

Pageof 10